Cardio Respiratory Physiological Assist Technology
Introducing a New Category
Of Heart Failure Treatment
CRPA :
Cardio-Respiratory
Physiological Assist
Heart failure remains one of the largest unmet needs in medicine, affecting 6.7 million people in the United States and 64 million worldwide. Patients face a relentless cycle of hospital readmissions, with 25 percent readmitted within 30 days of discharge.
Heart failure is the leading cause of hospitalization among U.S. Medicare beneficiaries, creating an economic burden exceeding $30 billion annually and projected to reach $70 billion by 2030.
Levron Medical introduces a novel and fresh approach to the treatment of Heart Failure, with elegance and simplicity like no other.
Events
2025
CSI - D-HF Conference - December 5-6, 2025 - Frankfurt, Germany
Dec 5th - Friday / 11:30 – 12:10 CET - Red room​
​​Electrophysiology techniques to manage heart failure​
Cardio-Respiratory Assist Device (CRPA) / Amir Landesberg/Amir Ronen
ICI Conference - December 7-9, 2025 - Tel Aviv, Israel
​
Dec 8th - Monday / 14:00 - 15:30 - Abstract Session
Amir Landesberg
​
Dec 9th - Tuesday / 16:00 - 17:15 - New Technologies/Start up Parade in HF
A Novel Paradigm in HF: How to Turn a Pacemaker into an Assist Device?
Amir Landesberg
News & Press release
2025
2024
Our Team
Amir Ronen is an entrepreneur and a seasoned executive in the Israeli hi-tech scene. A co-founder and CEO for 15 years in the Heart Failure medical device space, and previously a VP in NASDAQ traded companies all which have been merged and acquired (Sensible Medical $150M; M-Systems $1.4B; Saifun $384M). Amir holds a BsC in Electronic Engineering from the Technion and an MBA from Kellogg IMBA.
Professor and former dean of the biomedical engineering faculty at the Technion and former president of the International Society for Heart Research Israel group. Prof. Landesberg holds a Phd. In biomedical engineering and an M.D. Cum-Laude both from the Technion
Dr. Eckhouse is the founder and chairman of Alon MedTech ventures, a major player in the Israeli medical eco system, founded and invested in 20+ companies. such as Syneron Medical (acquired for $400M) and Ventor technologies (acquired for $325M)
Dr. Livneh is an R&D executive with extensive experience in preclinical and clinical cardiovascular research and development, specializing in real-time biomedical signal processing, machine learning and data science. Dr. Livneh holds a PhD. in Biomedical Engineering from the Technion, an MSc. in Electrical Engineering from Tel-Aviv University, and a BSc. in Electrical Engineering from the Technion.
Contact Us
Hatnufa 3 st. , 7th Floor
Industrial Park
Yokneam, Israel
+972-54-3113699